A Japanese company has received the green light to mass-manufacture a treatment for Parkinson’s that transplants stem cells directly into the brain. A 7-person study no adverse effects were observed and more than half the participants showed some signs of recovery buff.ly/JdSnIAx #ShareGoodNewsToo

Japan grants conditional appro...
Japan grants conditional approval to Amchepry for Parkinson’s

Japan granted conditional approval to Amchepry, a stem cell-derived therapy for Parkinson’s disease, based on early clinical trial results

Parkinson's News Today